Download PDF
Exp Clin Endocrinol Diabetes 2005; 113(4): 231-235
DOI: 10.1055/s-2005-837556
Article

J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Gonadoblastomas in 5 Patients with 46,XY Gonadal Dysgenesis

W. Hoepffner1 , L.-C. Horn2 , E. Simon3 , G. Sauerbrei4 , H. Schröder5 , B. Thamm-Mücke6 , J. Bennek7 , W. Kiess1
  • 1Children's Hospital of the University Clinical Center of Leipzig, Leipzig, Germany
  • 2Institute of Pathology of the University Clinical Center of Leipzig, Leipzig, Germany
  • 3Hospital „J. Kentmann gGmbH“, Torgau, Germany
  • 4Children's Hospital at the Clinical Center Erfurt GmbH, Erfurt, Germany
  • 5Hospital of Wittenberg, Wittenberg, Germany
  • 6Institute of Human Genetics of the University Clinical Center of Leipzig, Leipzig, Germany
  • 7Clinic of Pediatric Surgery of the University Clinical Center of Leipzig, Leipzig, Germany
Further Information

Publication History

Received: August 2, 2004 First decision: October 14, 2004

Accepted: November 19, 2004

Publication Date:
13 May 2005 (online)

Also available at
    Permissions and Reprints

Abstract

We describe five patients with 46,XY gonadal dysgenesis who developed gonadoblastomas, dysgerminomas, a mature teratoma, and a testicular intraepithelial neoplasia. The age of the patients was between 12.2 and 18.5 years. The external genitalia were normal female in two cases, in three they were intersexual. Four of our patients presented with slight retardation of puberty followed by stagnation. Most importantly the development of the breast (Tanner stage 2 - 4) did not correspond with pubic hair stage (Tanner stage 4). The patients can be classified as virilized phenotypical females. Serum testosterone was detectable in three, estradiol in two patients. None of the gonadoblastomas showed immunoreactivity with antibodies against steroid hormone receptors and against testosterone and estradiol, respectively. Probably the immature cells are able to produce steroid hormones. Only steroid-like cells with Leydig cell appearance showed positive cytoplasmatic immunostaining for testosterone in three patients. The findings in our patients underline that dysgenetic gonads must be removed as early as possible to prevent development of malignant tumors.

Key words

46,XY gonadal dysgenesis - male pseudohermaphroditism - gonadoblastoma - dysgerminoma - immunoreactivity

References

  • 1 Alikasifoglu A, Kandemir N, Caglar M, Kotiloglu E, Yordam N. Prepubertal gonadoblastoma in a 46,XY female patient with features of Turner syndrome.  Eur J Pediatr. 1996;  155 653-655
    CrossrefPubMedGoogle Scholar
  • 2 Barbosa A S, Ferraz-Costa T E, Semer M, Liberman B, Moreira. Filho CA. XY gonadal dysgenesis and gonadoblastoma: A study in two sisters with a cryptic deletion of the Y chromosome involving the SRY gene.  Hum Genet. 1995;  95 63-66
    PubMedGoogle Scholar
  • 3 Benini E, Rao S, Daidone M G, Pilotti S, Silvestrini R. Immunoreactivity to MIB-1 in breast cancer: Methodological assessment and comparison with other proliferation indices.  Cell Prolif. 1997;  30 107-115
    CrossrefPubMedGoogle Scholar
  • 4 Berkovitz G D, Fechner P Y, Zacur H W, Rock J A, Snyder H M, Migeon C J, Perlman E J. Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: Its relevance to the understanding of sex differentiation.  Medicine. 1991;  70 375-383
    PubMedGoogle Scholar
  • 5 Bosze P, Magyar E, Toth A. 45,X streak gonad syndrome associated with bilateral “burnt out” gonadoblastoma.  Gynecol Obstet Invest. 1989;  28 113-117
    PubMedGoogle Scholar
  • 6 Chen F P, Chu K K, Soong Y K. 46,XY pure gonadal dysgenesis with gonadoblastoma - a case report.  Chang Gung Med J. 1991;  14 264-268
    PubMedGoogle Scholar
  • 7 Dumic M, Jukic S, Batinica S, Ille J, Filipovic-Grcic B. Bilateral gonadoblastoma in a 9-month-old infant with 46,XY gonadal dysgenesis.  J Endocrinol Invest. 1993;  16 291-293
    PubMedGoogle Scholar
  • 8 Fukamatsu Y, Tsukahara Y, Hayashi S, Yoshikawa F, Fukuta T. Bilateral gonadoblastoma producing steroid hormones in a patient with 45,X/46,XY gonadal dysgenesis.  Gynecol Obstet Invest. 1990;  30 189-191
    PubMedGoogle Scholar
  • 9 Greulich W W, Pyle S I. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 2nd ed. Stanford; Stanford University Press 1959
    Google Scholar
  • 10 Hong J R, Barber M, Scott C I, Guttenberg M, Wolfson P J. 3-year-old phenotypic female with campomelic dysplasia and bilateral gonadoblastoma.  J Pediatr Surg. 1995;  30 1735-1737
    CrossrefPubMedGoogle Scholar
  • 11 Hussong J, Crussi F G, Chou P M. Gonadoblastoma: Immunohistochemical localization of Müllerian-inhibiting substance, inhibin, WT-1, and p53.  Mod Pathol. 1997;  10 1101-1105
    PubMedGoogle Scholar
  • 12 Iezzoni J C, von Kap-Herr C, Golden W L, Gaffay M J. Gonadoblastomas in 45,X/46,XY Mosaicism. Analysis of Y chromosome distribution by fluorescence in situ hybridization.  Am J Clin Pathol. 1997;  108 197-201
    PubMedGoogle Scholar
  • 13 Jäger R J, Anvret M, Hall K, Scherer G. A human XY female with a frame shift mutation in the candidate testis-determining gene SRY.  Nature. 1990;  348 452-454
    CrossrefPubMedGoogle Scholar
  • 14 Jorgensen N, Müller J, Jaubert F, Clausen O P, Skakkebaek N E. Heterogeneity of gonadoblastoma germ cells: Similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells.  Histopathology. 1997;  30 177-186
    CrossrefPubMedGoogle Scholar
  • 15 Kauf E, Hesse V. Hermaphroditismus mit Gonadoblastomentwicklung im Kindesalter.  Z Klin Med. 1989;  44 1449-1452
    PubMedGoogle Scholar
  • 16 Lange A, Wieacker P, Schweikart H U, Schumann K. Androgenproduzierendes Gonadoblastom bei reiner XY-Gonadendysgenesie (Swyer-Syndrom).  Zentralbl Gynäkol. 1998;  120 555-558
    PubMedGoogle Scholar
  • 17 Liu Y C, Wei T C, Hsu Y H, Fang J S, Lee M L. Gonadoblastoma and choriocarcinoma in dysgenetic gonads: Report of a case.  J Formos Med Assoc. 1995;  94 568-571
    PubMedGoogle Scholar
  • 18 Löffler S, Horn L C, Weber W, Spanel-Borowski K. The transient disappearance of cytokeratine in human fetal and adult ovaries.  Anat Embryol. 2000;  201 207-215
    CrossrefPubMedGoogle Scholar
  • 19 Lukusa T, Fryns J P, Kleczkowska A, van den Berghe H. Role of gonadal dysgenesis in gonadoblastoma induction in 46,XY individuals.  Genetic Counseling. 1991;  2 9-16
    PubMedGoogle Scholar
  • 20 Mackay A M, Pettigrew N, Symington T, Neville A M. Tumors of dysgenetic gonads (gonadoblastoma): Ultrastructural and steroidogenic aspects.  Cancer. 1974;  34 1108-1125
    PubMedGoogle Scholar
  • 21 Matias-Guiu X, Pons C, Prat J. Müllerian inhibiting substance, alpha-inhibin and CD 99 expression in sex cord-stromal tumors and endometrioid ovarian carcinomas resembling sex cord-stromal tumors.  Hum Pathol. 1998;  29 840-845
    CrossrefPubMedGoogle Scholar
  • 22 McDonald M T, Fleijter W, Sheldon S, Putzi M J, Gorski J L. XY sex reversal and gonadal dysgenesis due to 9 p24 monosomy.  Am J Med Genet. 1997;  73 321-326
    CrossrefPubMedGoogle Scholar
  • 23 Miettinen M, Talerman A, Wahlstrom T, Astengo-Osuna C, Virtanan I. Cellular differentiation in ovarian sex-cord-stromal and germ-cell tumors studied with antibodies to intermediate-filament proteins.  Am J Surg Pathol. 1985;  9 640-651
    PubMedGoogle Scholar
  • 24 Müller J, Visfeldt J, Philip J, Skakkebaek N E. Carcinoma in situ, gonadoblastoma, and early invasive neoplasia in a nine-year-old girl with 46,XY gonadal dysgenesis.  APMIS. 1992;  100 170-174
    PubMedGoogle Scholar
  • 25 Obata N H, Nakashima N, Kawai M, Kikkawa F, Mamba S, Tomoda Y. Gonadoblastoma with dysgerminoma in one ovary and gonadoblastoma with dysgerminoma and yolk sac tumor in the contralateral ovary in a girl with 46XX karyotype.  Gynecol Oncol. 1995;  58 124-128
    CrossrefPubMedGoogle Scholar
  • 26 Pelkey T J, Frierson H F, Mills S E. et al . The diagnostic utility of inhibin staining in ovarian neoplasms.  Int J Gynecol Pathol. 1998;  17 97-105
    PubMedGoogle Scholar
  • 27 Petersen L, Kock K, Jacobsen B B. Germ cell neoplasms in three intersex patients with 46,XY karyotype.  Intern Urol Nephrol. 1992;  24 633-639
    PubMedGoogle Scholar
  • 28 Prader A. Der Genitalbefund beim Pseudohermaphroditismus femininus des kongenitalen adrenogenitalen Syndroms.  Helv Paediatr Acta. 1954;  9 231-248
    PubMedGoogle Scholar
  • 29 Quigley M M, Vaughn T C, Hammond C B, Haney A F. Production of testosterone and estrogen in vitro by gonadal tissue from a 46,XY true hermaphrodite with gonadal failure and gonadoblastoma.  Obstet Gynecol. 1981;  58 253-259
    PubMedGoogle Scholar
  • 30 Ramani P, Yeung C K, Habeebu S SM. Testicular intratubular germ cell neoplasia in children and adolescents with intersex.  Am J Surg Pathol. 1993;  17 1124-1133
    PubMedGoogle Scholar
  • 31 Roth L M, Eglen D E. Gonadoblastoma: Immunohistochemical and ultrastructural observations.  Int J Gynecol Pathol. 1989;  8 72-81
    PubMedGoogle Scholar
  • 32 Rutgers J L. Advances in the pathology of intersex conditions.  Hum Pathol. 1991;  22 884-891
    CrossrefPubMedGoogle Scholar
  • 33 Sadi A M, Toda T, Kiyuna M, Miyagi H. Mixed gonadal dysgenesis with gonadoblastoma in a female with Y chromosome: Case report.  J Obstet Gynaecol Res. 1996;  22 25-30
    PubMedGoogle Scholar
  • 34 Schellas H F. Malignant potential of dysgenetic gonad. Part II.  Obstet Gynecol. 1974;  44 455-462
    PubMedGoogle Scholar
  • 35 Scully R E. Gonadoblastoma: A gonadal tumor related to the dysgerminoma (seminoma) and capable of sex hormone production.  Cancer. 1953;  6 455-463
    CrossrefPubMedGoogle Scholar
  • 36 Scully R E. Gonadoblastoma: A review of 74 cases.  Cancer. 1970;  25 1340-1356
    CrossrefPubMedGoogle Scholar
  • 37 Scully R E. Neoplasia associated with anomalous sexual development and abnormal sex chromosomes.  Pediatr Adolesc Endocrinol. 1981;  8 203-217
    PubMedGoogle Scholar
  • 38 Slowikowska-Hilczer J, Szarras-Czapnik M, Kula K. Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: An approach to pathogenesis of testis cancer.  J Androl. 2001;  22 781-792
    PubMedGoogle Scholar
  • 39 Slowikowska-Hilczer J, Romer T E, Kula K. Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype.  J Androl. 2003;  24 270-278
    PubMedGoogle Scholar
  • 40 Tanner J M. Growth at Adolescence. 2nd ed. Oxford, Edinburgh; Blackwell 1962
    Google Scholar
  • 41 Thamm B. Direct non-isotopic sequencing of PCR products or standards. Köhler T, Lassner D, Rost AK, Thamm B, Pustoweit B, Remke H Quantitation of mRNA by Polymerase Chain Reaction. Berlin, Heidelberg, New York; Springer 1995: 39-51
    Google Scholar

Dr. med. W. Hoepffner

Children's Hospital of the University of Leipzig

Oststraße 21 - 25

04317 Leipzig

Germany

Phone: + 493419726148

Fax: + 49 34 19 72 61 49

Email: Ruth.Gausche@medizin.uni-leipzig.de

      >